1009071-34-4 Usage
General Description
1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester, also known as Boc-3-Methylpyrazole-4-boronic acid pinacol ester, is a chemical compound that is commonly used in organic synthesis. It is a boronic acid ester, which means it contains a boron atom bonded to an oxygen atom and an alkyl group. 1-Boc-3-Methylpyrazole-4-boronic acid pinacol ester is often used as a reagent in the synthesis of pharmaceuticals and other organic molecules. It can react with various nucleophiles, such as alcohols and amines, to form new carbon-carbon and carbon-heteroatom bonds. Its unique structure and reactivity make it a valuable tool for chemists working in the field of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1009071-34-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,0,7 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1009071-34:
(9*1)+(8*0)+(7*0)+(6*9)+(5*0)+(4*7)+(3*1)+(2*3)+(1*4)=104
104 % 10 = 4
So 1009071-34-4 is a valid CAS Registry Number.
1009071-34-4Relevant articles and documents
THIENOPYRIMIDINE AS CDC7 KINASE INHIBITORS
-
Page/Page column 203-204, (2010/09/18)
The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a prodrug thereof, which is useful for the prophylaxis or treatment of cancer
HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
Page/Page column 184, (2008/12/05)
Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.